Cherry juice tested as shield against chemo nerve pain

NCT ID NCT06268665

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2 trial tests whether drinking tart cherry juice can prevent nerve damage (neuropathy) caused by the chemotherapy drug paclitaxel in breast and ovarian cancer patients. About 86 participants will be randomly assigned to receive either a high or low dose of the juice during their 12-week chemotherapy. The study aims to see if the supplement reduces neuropathy symptoms like numbness, tingling, or pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tart cherry juice
What this could lead to
If it works, this could offer a simple, natural way to prevent painful nerve damage during chemotherapy.
What could go wrong
This is a small, early-phase trial with only 86 participants, so results may not apply to everyone. The juice might not prevent neuropathy, and high doses could cause stomach upset.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California Davis Comprehensive Cancer Center

    RECRUITING

    Sacramento, California, 95827, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.